Recent progress of graphene oxide as a potential vaccine carrier and adjuvant

Wanjun Cao,Lin He,Weidong Cao,Xiaobing Huang,Kun Jia,Jingying Dai

DOI: https://doi.org/10.1016/j.actbio.2020.06.009

IF: 10.633

2020-08-01

Acta Biomaterialia

Abstract:<p>Vaccine is one of the most effective strategies for preventing and controlling infectious diseases and some noninfectious diseases, especially cancers. Adjuvants and carriers have been appropriately added to the vaccine formulation to improve the immunogenicity of the antigen and induce long-lasting immunity. However, there is an urgent need to develop new all-purpose adjuvants because some adjuvants approved for human use have limited functionality. Graphene oxide (GO), widely employed for the delivery of biomolecules, excels in loading and delivering antigen and shows the potentiality of activating the immune system. However, GO aggregates in biological liquid and induces cell death, and it also exhibits poor biosolubility and biocompatibility. To address these limitations, various surface modification protocols have been employed to integrate aqueous compatible substances with GO to effectively improve its biocompatibility. More importantly, these modifications render functionalized-GO with superior properties as both carriers and adjuvants. Herein, the recent progress of physicochemical properties and surface modification strategies of GO for its application as both carriers and adjuvants is reviewed.</p>

engineering, biomedical,materials science, biomaterials

What problem does this paper attempt to address?

The paper primarily explores the potential applications of Graphene Oxide (GO) as a vaccine carrier and adjuvant, and proposes solutions to its limitations in the biomedical field. Specifically:

1. **Research Background**:
- Vaccines are one of the effective means to prevent and control infectious diseases and certain non-infectious diseases (such as cancer).
- To enhance the immunogenicity of antigens and induce long-lasting immunity, adjuvants and carriers are usually added to vaccine formulations.
- The currently approved adjuvants for human use have limited functions, thus there is an urgent need to develop new universal adjuvants.

2. **Characteristics and Challenges of Graphene Oxide**:
- Graphene Oxide shows potential as a vaccine carrier due to its unique physicochemical properties, such as high loading capacity and good antigen delivery capability.
- However, GO tends to aggregate in biological fluids, leading to cell death, and exhibits poor biocompatibility and solubility.

3. **Surface Modification Strategies**:
- To overcome these limitations, researchers have adopted various surface modification methods to integrate water-soluble substances into GO, effectively improving its biocompatibility.
- These modified functionalized Graphene Oxide (FGO) not only have better loading capacity but also can activate the immune system, demonstrating dual advantages as carriers and adjuvants.

4. **Specific Application Examples**:
- The paper lists several experimental cases showing the high efficiency of FGO in vaccine delivery, including efficient antigen loading, enhanced phagocytosis by immune cells, and promotion of specific cytokine secretion.
- Additionally, FGO can also load immune adjuvants (such as CpG oligonucleotides), further enhancing the overall immune effect of the vaccine.

In summary, the paper aims to overcome the inherent limitations of Graphene Oxide through functionalized modifications, thereby developing a new, efficient vaccine carrier and adjuvant system.